News & Highlights
Judy Tung, MD, will be joining NewYork-Presbyterian/Lower Manhattan Hospital (NYP/LMH) to serve as Chair of the Department of Medicine as of January 2016. A leading expert in internal medicine and primary care, Dr. Tung also specializes in women's health.
Dr. Monika Safford has been appointed to Chief of the Division of General Internal Medicine in the Weill Department of Medicine effective January 1, 2016. Recruited from the University of Alabama at Birmingham School of Medicine (UAB), she is a leading scholar in the field of internal medicine.
Steven M. Lipkin, M.D., Ph.D., Associate Professor of Medicine, Division of Gastroenterology and Hepatology, has been named as Vice Chair for Basic and Translational Research in the Weill Department of Medicine. Dr. Lipkin will work closely with departmental and divisional leadership to enhance and foster the research activities of our faculty and trainees.
Dr. David Artis, a world renowned expert in immunology and inflammatory bowel disease research and Director of the Jill Roberts Institute for Research in Inflammatory Bowel Disease, has published a landmark paper in PNAS that provides new insight on how the intestines repair themselves after daily attacks from microbes and environmental triggers. The researchers have uncovered a self-repair mechanism that could lead to innovative approaches for the treatment of IBD (inflammatory bowel diseases) and other intestinal disorders.
End-of-Life Chemotherapy for Cancer Patients in Question: Dr. Prigerson Publishes Landmark Findings in JAMA Oncology
Challenging widespread clinical practice and accepted treatment guidelines, Dr. Holly Prigerson, Irving Sherwood Wright Professor in Geriatrics, has published a paper in JAMA Oncology that puts the value of chemotherapy for end-of-life patients with cancer into question. Among several findings, it was found that patients who were ambulatory (able to do light work) and receiving chemotherapy at study entry, had significantly lower quality of life at the end of their lives compared to those who were not received chemotherapy.
Robert S. Brown, Jr., MD, MPH, has been appointed to Vice Chair of Transitions of Care for the Weill Department of Medicine (WDOM). He is the Interim Chief of the Division of Gastroenterology and Hepatology and the Director of the Center for Liver Disease and Transplantation at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Additionally, Dr. Brown holds the title of Professor of Clinical Medicine at Columbia University College of Physicians & Surgeons.
SLE, Pregnancy, Predictors, and Outcomes: Dr. Salmon & Colleagues Publish Pivotal Paper in Annals of Internal Medicine
Dr. Jane Salmon, Professor of Medicine in the Weill Department of Medicine and Collette Kean Research Chair at Hospital for Special Surgery, has published a pivotal paper, "Predictors of Pregnancy Outcomes in Patients with Lupus – A Cohort Study," in the Annals of Internal Medicine. In this multicenter study, Dr. Salmon and colleagues identified clinical and laboratory predictors of adverse pregnancy outcomes in women who have inactive or stable-mild active lupus.
Improving the Odds for People with Non-Hodgkin Lymphoma: Division of Hematology and Medical Oncology Takes the Lead
The Mayo Clinic has received an $11 million grant from the National Cancer Institute to support research addressing current and long-term unmet healthcare needs of people with non-Hodgkin lymphoma (NHL). The NCI-funded project known as the "Lymphoma Epidemiology of Outcomes Cohort Study" is a collaborative effort among multiple institutions. Dr. Peter Martin, Assistant Professor of Medicine, is serving as the Weill Cornell site Principal Investigator for this study, and Dr. John Leonard, the department's Vice Chair for Clinical Research, is a participating investigator.
On June 4, 2015, the Weill Department of Medicine hosted a retirement party at Griffis Faculty Club for Ralph L. Nachman, M.D., who had served as the department's chairman for two decades. From far and wide, colleagues, friends and family were in attendance to celebrate Dr. Nachman's extraordinary career as a physician, scientist, mentor, and administrator. Speeches were given by those who have worked closely with Dr. Nachman and/or had been trained by him at Weill Cornell.
Dr. Gregory F. Sonnenberg, newly recruited to the Division of Gastroenterology and Hepatology, has published breakthrough findings in Science on how the immune system prevents chronic inflammation in the intestine. In earlier research, he and his team had identified a new member of the innate immune system – innate lymphoid cells (ILCs) which interact with T cells in the GI tract. The new findings in Science reveal that ILCs directly educate T cells in the intestine to not attack beneficial bacteria, and that impairment of ILC function leads to severe intestinal inflammation.
Headstrong Project Receives the Morgan Stanley Strategy Challenge: A Model of Success for the Treatment of PTSD
The Weill Cornell Headstrong Project has been selected by Morgan Stanley as one nine recipients to receive the Morgan Stanley Strategy Challenge. The "Challenge" will assist the Headstrong Program in NYC to replicate their model of treatment for PTSD in post-9/11 veterans who live in other cities in the U.S.
Dr. Francine Garrett-Bakelman recently spoke at the SNMA's Medical Education Conference (AMEC) held in New Orleans. An Instructor in Medicine, Division of Hematology and Medical Oncology, she was highlighted as one of four physician-scientists at the conference's Grand Rounds opening session.
An exciting "Reading and Discussion" event will take place on April 8th regarding the new book, The Real Doctor Will See You Shortly: A Physician's First Year, written by Dr. Matthew McCarthy, an Assistant Attending Physician in the Division of Hospital Medicine. The talk is part of Medical Humanities Round, The Liz Claiborne Center for Humanism in Medicine, Division of Geriatrics and Palliative Medicine.
Dr. Andrew I. Schafer gave the Keynote Address at the spring meeting of the Royal College of Physicians in London on Feb. 27, 2015, to an audience that included HRH Princess Anne. In his address, Dr. Schafer talked about the future of academic medicine, comparing and contrasting the situations in the U.S. and the United Kingdom and Europe, in areas such as medical education and research funding.
The Department of Medicine is pleased to offer our next conference in the Basic Science continuing medical education series. The Basic Neurobiology for Physicians Course, co-directed by Dr. Howard Goldin and Dr. Lia Logio, will be taught by expert faculty members of WCMC and The Rockefeller University.
Weill Department of Medicine Fostering a New Generation of Investigators: WDOM Junior Faculty Presentations a Model of Success
The Weill Department of Medicine is focused on increasing its research footprint both at Weill Cornell and on a national level. To that end, the department has established a mentoring infrastructure to assist junior faculty during their transition to NIH K and R series grants. This infrastructure supports a monthly meeting that seeks to build, promote, and mentor the department's junior faculty.